DK1206495T3 - Kimære polypeptider, fremgangsmåde til frembringelse og anvendelser deraf - Google Patents
Kimære polypeptider, fremgangsmåde til frembringelse og anvendelser derafInfo
- Publication number
- DK1206495T3 DK1206495T3 DK00948017T DK00948017T DK1206495T3 DK 1206495 T3 DK1206495 T3 DK 1206495T3 DK 00948017 T DK00948017 T DK 00948017T DK 00948017 T DK00948017 T DK 00948017T DK 1206495 T3 DK1206495 T3 DK 1206495T3
- Authority
- DK
- Denmark
- Prior art keywords
- production
- chimeric polypeptides
- chimeric
- polypeptides
- Prior art date
Links
- 229920001184 polypeptide Polymers 0.000 title 1
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
- C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
- C07K2317/624—Disulfide-stabilized antibody (dsFv)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/22011—Polyomaviridae, e.g. polyoma, SV40, JC
- C12N2710/22022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/22011—Polyomaviridae, e.g. polyoma, SV40, JC
- C12N2710/22023—Virus like particles [VLP]
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Engineering & Computer Science (AREA)
- General Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP99115022A EP1074563A1 (en) | 1999-08-02 | 1999-08-02 | Chimeric polypeptides enhancing dimer formation through electrostatic interactions and disulfide bond, method for production and uses thereof |
PCT/EP2000/007378 WO2001009193A1 (en) | 1999-08-02 | 2000-07-31 | Chimeric polypeptides, method for production and uses thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1206495T3 true DK1206495T3 (da) | 2007-06-11 |
Family
ID=8238697
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK00948017T DK1206495T3 (da) | 1999-08-02 | 2000-07-31 | Kimære polypeptider, fremgangsmåde til frembringelse og anvendelser deraf |
Country Status (17)
Country | Link |
---|---|
US (1) | US6437095B1 (ko) |
EP (2) | EP1074563A1 (ko) |
JP (1) | JP4011914B2 (ko) |
KR (1) | KR100484084B1 (ko) |
CN (1) | CN1184235C (ko) |
AR (1) | AR021448A1 (ko) |
AT (1) | ATE353921T1 (ko) |
AU (1) | AU768645B2 (ko) |
BR (1) | BR0012926A (ko) |
CA (1) | CA2380569C (ko) |
DE (1) | DE60033405T2 (ko) |
DK (1) | DK1206495T3 (ko) |
ES (1) | ES2280231T3 (ko) |
MX (1) | MXPA02001139A (ko) |
TR (1) | TR200200252T2 (ko) |
WO (1) | WO2001009193A1 (ko) |
ZA (1) | ZA200109746B (ko) |
Families Citing this family (46)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7192596B2 (en) * | 1996-08-23 | 2007-03-20 | The Health Protection Agency Ipsen Limited | Recombinant toxin fragments |
US20030157091A1 (en) * | 2002-02-14 | 2003-08-21 | Dyax Corporation | Multi-functional proteins |
US7335361B2 (en) * | 2003-06-09 | 2008-02-26 | Animal Technology Institute Taiwan | Fusion antigen used as vaccine |
US7348399B2 (en) | 2003-08-29 | 2008-03-25 | Louisiana Tech University Foundation, Inc. | Nanofabricated polypeptide multilayer films, coatings, and microcapsules |
US7544770B2 (en) * | 2003-08-29 | 2009-06-09 | Louisiana Tech Foundation, Inc. | Multilayer films, coatings, and microcapsules comprising polypeptides |
US7550557B2 (en) | 2003-08-29 | 2009-06-23 | Louisiana Tech University Foundation, Inc. | Multilayer films, coatings, and microcapsules comprising polypeptides |
CA2587643C (en) * | 2004-11-22 | 2013-09-24 | Louisiana Tech University Foundation | Method for designing polypeptides for the nanofabrication of thin films, coatings, and microcapsules by electrostatic layer-by-layer self assembly |
US20090246127A1 (en) * | 2004-12-17 | 2009-10-01 | Koninklijke Philips Electronics, N.V. | Targeting agents for molecular imaging |
CN104945509A (zh) | 2009-09-16 | 2015-09-30 | 弗·哈夫曼-拉罗切有限公司 | 包含卷曲螺旋和/或系链的蛋白质复合体及其用途 |
TW201138821A (en) | 2010-03-26 | 2011-11-16 | Roche Glycart Ag | Bispecific antibodies |
CN103384831B (zh) | 2010-12-23 | 2016-02-10 | 霍夫曼-拉罗奇有限公司 | 通过二价结合剂来检测多肽二聚体 |
WO2012085064A1 (en) | 2010-12-23 | 2012-06-28 | Roche Diagnostics Gmbh | Detection of a posttranslationally modified polypeptide by a bi-valent binding agent |
CN103384681B (zh) | 2010-12-23 | 2018-05-18 | 霍夫曼-拉罗奇有限公司 | 结合剂 |
EP2655413B1 (en) | 2010-12-23 | 2019-01-16 | F.Hoffmann-La Roche Ag | Polypeptide-polynucleotide-complex and its use in targeted effector moiety delivery |
WO2012107932A1 (en) * | 2011-02-11 | 2012-08-16 | Transgene Biotek Ltd. | B cell clonal immunotoxin and use thereof |
WO2012171996A1 (en) | 2011-06-15 | 2012-12-20 | F. Hoffmann-La Roche Ag | Anti-human epo receptor antibodies and methods of use |
WO2013119966A2 (en) | 2012-02-10 | 2013-08-15 | Genentech, Inc. | Single-chain antibodies and other heteromultimers |
JP6203838B2 (ja) | 2012-06-27 | 2017-09-27 | エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft | 少なくとも2つの異なる結合実体を含む、テーラーメイドの高度に選択的かつ多重特異的なターゲティング実体を選択および作製するための方法、ならびにその使用 |
WO2014001325A1 (en) | 2012-06-27 | 2014-01-03 | F. Hoffmann-La Roche Ag | Method for making antibody fc-region conjugates comprising at least one binding entity that specifically binds to a target and uses thereof |
CA2871386A1 (en) | 2012-06-27 | 2014-01-03 | F. Hoffmann-La Roche Ag | Method for the selection and production of tailor-made, selective and multi-specific therapeutic molecules comprising at least two different targeting entities and uses thereof |
MX371403B (es) | 2014-03-20 | 2020-01-29 | Bristol Myers Squibb Co | Moleculas de andamiaje a base de fibronectina estabilizada. |
ES2755395T3 (es) | 2014-06-06 | 2020-04-22 | Bristol Myers Squibb Co | Anticuerpos contra el receptor del factor de necrosis tumoral inducido por glucocorticoides (GITR) y usos de los mismos |
US10100129B2 (en) | 2014-11-21 | 2018-10-16 | Bristol-Myers Squibb Company | Antibodies against CD73 and uses thereof |
JP6622814B2 (ja) | 2014-11-25 | 2019-12-18 | ブリストル−マイヤーズ スクイブ カンパニーBristol−Myers Squibb Company | イメージングのための新規pd−l1結合ポリペプチド |
PL3227332T3 (pl) | 2014-12-03 | 2020-06-15 | F. Hoffmann-La Roche Ag | Wielospecyficzne przeciwciała |
EP3945096A1 (en) | 2014-12-19 | 2022-02-02 | Regenesance B.V. | Antibodies that bind human c6 and uses thereof |
WO2016127052A1 (en) | 2015-02-05 | 2016-08-11 | Bristol-Myers Squibb Company | Cxcl11 and smica as predictive biomarkers for efficacy of anti-ctla4 immunotherapy |
SG10202008304TA (en) | 2015-05-29 | 2020-10-29 | Bristol Myers Squibb Co | Antibodies against ox40 and uses thereof |
CN108884147B (zh) | 2015-09-23 | 2024-02-27 | 百时美施贵宝公司 | 结合磷脂酰肌醇蛋白聚糖3的基于纤连蛋白的支架分子 |
SG11201803817PA (en) | 2015-11-19 | 2018-06-28 | Bristol Myers Squibb Co | Antibodies against glucocorticoid-induced tumor necrosis factor receptor (gitr) and uses thereof |
BR112018067368A2 (pt) | 2016-03-04 | 2019-01-15 | Bristol-Myers Squibb Company | terapia de combinação com anticorpos anti-cd73 |
EP3463486A1 (en) | 2016-06-01 | 2019-04-10 | Bristol-Myers Squibb Company | Pet imaging with pd-l1 binding polypeptides |
MY200602A (en) | 2016-07-14 | 2024-01-04 | Bristol Myers Squibb Co | Antibodies against tim3 and uses thereof |
WO2018083538A1 (en) | 2016-11-07 | 2018-05-11 | Neuracle Scienc3 Co., Ltd. | Anti-family with sequence similarity 19, member a5 antibodies and method of use thereof |
TWI788321B (zh) * | 2017-01-20 | 2023-01-01 | 美商健臻公司 | 骨靶向抗體 |
CA3051839A1 (en) | 2017-02-17 | 2018-08-23 | Bristol-Myers Squibb Company | Antibodies to alpha-synuclein and uses thereof |
CN111886255A (zh) | 2018-01-12 | 2020-11-03 | 百时美施贵宝公司 | 抗tim3抗体及其用途 |
US11242393B2 (en) | 2018-03-23 | 2022-02-08 | Bristol-Myers Squibb Company | Antibodies against MICA and/or MICB and uses thereof |
TWI790370B (zh) | 2018-04-02 | 2023-01-21 | 美商必治妥美雅史谷比公司 | 抗trem-1抗體及其用途 |
WO2020003210A1 (en) | 2018-06-29 | 2020-01-02 | Kangwon National University University-Industry Cooperation Foundation | Anti-l1cam antibodies and uses thereof |
BR112021014106A2 (pt) | 2019-01-22 | 2021-10-13 | Bristol-Myers Squibb Company | Anticorpos contra subunidade alfa de il-7r e usos dos mesmos |
CN114805598A (zh) * | 2019-04-28 | 2022-07-29 | 广州市雷德生物科技有限公司 | 促进蛋白二聚体形成的拉链扣结构及其应用 |
US20220372139A1 (en) | 2019-07-15 | 2022-11-24 | Bristol-Myers Squibb Company | Anti-trem-1 antibodies and uses thereof |
WO2021011681A1 (en) | 2019-07-15 | 2021-01-21 | Bristol-Myers Squibb Company | Antibodies against human trem-1 and uses thereof |
CN112694527B (zh) * | 2020-12-25 | 2022-09-09 | 山东睿鹰制药集团有限公司 | 一种重组人干扰素-κ包涵体的纯化和复性方法 |
JP2024514530A (ja) | 2021-04-02 | 2024-04-02 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | 切断型cdcp1に対する抗体およびその使用 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK132892D0 (da) * | 1992-10-30 | 1992-10-30 | Novo Nordisk As | Proteiner |
US5747654A (en) * | 1993-06-14 | 1998-05-05 | The United States Of America As Represented By The Department Of Health And Human Services | Recombinant disulfide-stabilized polypeptide fragments having binding specificity |
WO1998050431A2 (en) * | 1997-05-02 | 1998-11-12 | Genentech, Inc. | A method for making multispecific antibodies having heteromultimeric and common components |
-
1999
- 1999-08-02 EP EP99115022A patent/EP1074563A1/en not_active Withdrawn
-
2000
- 2000-07-24 AR ARP000103808A patent/AR021448A1/es active IP Right Grant
- 2000-07-26 US US09/625,570 patent/US6437095B1/en not_active Expired - Lifetime
- 2000-07-31 DE DE60033405T patent/DE60033405T2/de not_active Expired - Lifetime
- 2000-07-31 JP JP2001513999A patent/JP4011914B2/ja not_active Expired - Lifetime
- 2000-07-31 EP EP00948017A patent/EP1206495B1/en not_active Expired - Lifetime
- 2000-07-31 AU AU61610/00A patent/AU768645B2/en not_active Ceased
- 2000-07-31 CN CNB008095159A patent/CN1184235C/zh not_active Expired - Fee Related
- 2000-07-31 CA CA002380569A patent/CA2380569C/en not_active Expired - Fee Related
- 2000-07-31 TR TR2002/00252T patent/TR200200252T2/xx unknown
- 2000-07-31 ES ES00948017T patent/ES2280231T3/es not_active Expired - Lifetime
- 2000-07-31 WO PCT/EP2000/007378 patent/WO2001009193A1/en active IP Right Grant
- 2000-07-31 KR KR10-2002-7001377A patent/KR100484084B1/ko not_active IP Right Cessation
- 2000-07-31 DK DK00948017T patent/DK1206495T3/da active
- 2000-07-31 AT AT00948017T patent/ATE353921T1/de active
- 2000-07-31 BR BR0012926-7A patent/BR0012926A/pt not_active IP Right Cessation
- 2000-07-31 MX MXPA02001139A patent/MXPA02001139A/es active IP Right Grant
-
2001
- 2001-11-27 ZA ZA200109746A patent/ZA200109746B/en unknown
Also Published As
Publication number | Publication date |
---|---|
ZA200109746B (en) | 2003-03-12 |
JP4011914B2 (ja) | 2007-11-21 |
JP2003506028A (ja) | 2003-02-18 |
EP1074563A1 (en) | 2001-02-07 |
CA2380569A1 (en) | 2001-02-08 |
DE60033405D1 (de) | 2007-03-29 |
US6437095B1 (en) | 2002-08-20 |
AR021448A1 (es) | 2002-07-17 |
AU6161000A (en) | 2001-02-19 |
ES2280231T3 (es) | 2007-09-16 |
KR20020026558A (ko) | 2002-04-10 |
ATE353921T1 (de) | 2007-03-15 |
TR200200252T2 (tr) | 2002-05-21 |
EP1206495B1 (en) | 2007-02-14 |
BR0012926A (pt) | 2002-04-30 |
CN1358198A (zh) | 2002-07-10 |
KR100484084B1 (ko) | 2005-04-20 |
CN1184235C (zh) | 2005-01-12 |
EP1206495A1 (en) | 2002-05-22 |
AU768645B2 (en) | 2003-12-18 |
DE60033405T2 (de) | 2007-10-31 |
WO2001009193A1 (en) | 2001-02-08 |
MXPA02001139A (es) | 2002-08-20 |
CA2380569C (en) | 2008-01-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1206495T3 (da) | Kimære polypeptider, fremgangsmåde til frembringelse og anvendelser deraf | |
NO20012158D0 (no) | Substituerte 2-fenylbenzimidazoler, fremgangsmåte til fremstilling og anvendelse derav | |
DK1259547T3 (da) | Højpotente, rekombinante antistoffer og fremgangsmåde til fremstilling heraf | |
DK1185536T3 (da) | Hemisyntesefremgangsmåde og mellemprodukter deraf | |
IS6182A (is) | A-beta peptíði og ferli til að búa þær til | |
DK1436309T3 (da) | BGL3-beta-glukosidase og nukleinsyrer kodende derfor | |
DK0969694T3 (da) | Tryktransducer og fremgangsmåde til fremstilling heraf | |
NO20001330D0 (no) | Produksjonsmetode for hydrater og anordning for utførelse av samme | |
IS6487A (is) | Aðferð til framleiðslu á Sítalóprami | |
NO20051875D0 (no) | Kjoleror og fremgangsmate for bruk av dette | |
IS5884A (is) | Aðferð til framleiðslu á hreinu sítalóprami | |
DK1261697T3 (da) | Kuldeaktiv beta-galactosidase, fremgangsmåde til fremstilling heraf og anvendelsen deraf | |
IS5982A (is) | Aðferð til framleiðslu á 5-sýanóþalíði | |
IS7848A (is) | Essítalópram hýdróbrómíð og aðferð til framleiðslu þess | |
DK0991666T3 (da) | Alfa-1-antitrypsin-præparat og fremgangsmåde til fremstilling heraf | |
NO20022605D0 (no) | Kjemiske fremgangsmåter og mellomprodukter | |
DK1399424T3 (da) | Fremgangsmåde til fremstilling af 10,11-dihydro-10-hydroxy-5H-dibenz[b,f]azepin-5-carboxamid og 10,11-dihydro-10-oxo-5H-dibenz[b,f]azepin-5-carboxamid | |
DE60044525D1 (de) | Gassensor und dessen Herstellungsverfahren | |
NO20000383L (no) | Forlengingsrørsammenstilling og fremgangsmÕte til setting av samme | |
MXPA03008005A (es) | Metodo para la coloracion de material poroso. | |
GB0115204D0 (en) | Ceramic materials, method for their production and use thereof | |
NO20010254L (no) | Komposittprodukt og fremgangsmåte til fremstilling av dette | |
DK1361797T3 (da) | Cremet næringsmiddel og fremgangsmåde til fremstilling deraf | |
IS6068A (is) | Nýtt súrheyshjálparefni, aðferð til að framleiða þetta súrheyshjálparefni og notkun þessa súrheyshjálparefnis | |
GB2384779B (en) | Method for the production of tagged proteins |